3,3',4'-trihydroxyflavone has been researched along with acacetin in 2 studies
| Studies (3,3',4'-trihydroxyflavone) | Trials (3,3',4'-trihydroxyflavone) | Recent Studies (post-2010) (3,3',4'-trihydroxyflavone) | Studies (acacetin) | Trials (acacetin) | Recent Studies (post-2010) (acacetin) |
|---|---|---|---|---|---|
| 39 | 0 | 22 | 231 | 1 | 159 |
| Protein | Taxonomy | 3,3',4'-trihydroxyflavone (IC50) | acacetin (IC50) |
|---|---|---|---|
| Cytochrome P450 1A1 | Homo sapiens (human) | 0.083 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.1655 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.167 | |
| Potassium voltage-gated channel subfamily A member 5 | Homo sapiens (human) | 3.3 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.049 | |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | 0.6967 | |
| Mitogen-activated protein kinase 10 | Homo sapiens (human) | 5.78 | |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 5.78 | |
| Cytochrome P450 1B1 | Homo sapiens (human) | 0.011 | |
| Inositol hexakisphosphate kinase 2 | Homo sapiens (human) | 5.7 | |
| Potassium voltage-gated channel subfamily D member 3 | Homo sapiens (human) | 9.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Domina, NG; Khlebnikov, AI; Kirpotina, LN; Quinn, MT; Schepetkin, IA | 1 |
| Fernandes, E; Fernandes, PA; Freitas, M; Oliveira, A; Proença, C; Ramos, MJ; Ribeiro, D; Silva, AMS; Sousa, JLC | 1 |
2 other study(ies) available for 3,3',4'-trihydroxyflavone and acacetin
| Article | Year |
|---|---|
Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems.
Topics: Animals; Antioxidants; Drug Design; Flavonoids; Humans; Phagocytes; Phenols; Polyphenols; Quantitative Structure-Activity Relationship | 2007 |
Structural Specificity of Flavonoids in the Inhibition of Human Fructose 1,6-Bisphosphatase.
Topics: Drug Design; Enzyme Inhibitors; Flavonoids; Fructose; Fructose-Bisphosphatase; Humans; Hypoglycemic Agents; Liver; Molecular Structure | 2020 |